🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
The goal of this clinical investigation is to asses the safety and efficacy...
Status
Unknown
Location
CHU de Caen
Start Date
2024-03-11
Trial ID
NCT06024135
Treatments Being Tested
This is a Phase I, proof-of-concept treatment study to evaluate the safety,...
Status
Completed
Location
Johns Hopkins Outpatient Center
Start Date
2019-04-17
Trial ID
NCT03792516
Treatments Being Tested
COPD is a lung disease in which the lung is damaged, making it hard to brea...
Status
Unknown
Location
King Edward VII Hospital (Imperial College, London)
Start Date
2008-07
Trial ID
NCT00883584
The study will evaluate the pharmacokinetics (PK) of AZD6793 when administe...
Status
Completed
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06494644
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584